Production and uses of glyco-engineered CAR-T cells for the improvement of immunotherapy compositions for treatment of solid tumors. This therapeutic tools seems promising to cure cancer, reduce (recurrent) tumor growth and tumor burden, as well as to prevent relapse.
VIB & Ghent University – Nico Callewaert; Nele Festjens; Elien De Bousser
